Prostate Cancer
Silver Nanoparticles (AgNPs) Uptake by Caveolae-Dependent Endocytosis is Responsible for Their Selective Effect Towards Castration Resistant Prostate Cancer.
September 12, 2024
Oncologic Outcomes of Incidental Versus Biopsy-diagnosed Grade Group 1 Prostate Cancer: A Multi-institutional Study.
September 12, 2024
Amiloride Sensitizes Prostate Cancer Cells to the Reversible Tyrosine Kinase Inhibitor Lapatinib by Modulating ERBB3 Subcellular Localization.
September 12, 2024
Study Confirms AI Outperforms Conventional Methods for Prostate Cancer Extracapsular Extension Detection, Offering More Accurate Risk Assessments for Surgical Decisions
September 11, 2024
Extracapsular extension risk assessment using an artificial intelligence prostate cancer mapping algorithm
September 11, 2024
Testosterone recovery after androgen deprivation therapy.
September 11, 2024
Hospital-Level Variability in the Adoption of Image-Guided Focal Therapy for Localized Prostate and Kidney Cancer.
September 11, 2024
Artificial Intelligence Improves the Ability of Physicians to Identify Prostate Cancer Extent.
September 11, 2024
A new silicon phthalocyanine dye induces pyroptosis in prostate cancer cells during photoimmunotherapy.
September 10, 2024
Emergency and non-emergency routes to cancer diagnoses in 2020 and 2021: A Population-based study of 154,863 patients.
September 10, 2024
Effect of concomitant medications on treatment response and survival in non-metastatic castrate resistant prostate cancer: Exploratory analysis of the SPARTAN trial.
September 10, 2024
Apalutamide for non-metastatic castration-resistant prostate cancer (nmCRPC): real world data of a multicenter study.
September 10, 2024
Predictive factors of hemoglobin drop after robot-assisted radical prostatectomy: a single center prospective study.
September 10, 2024
Treatment Patterns and Survival Outcomes Among Androgen Receptor Pathway Inhibitor-Experienced Patients With Metastatic Castration-Resistant Prostate Cancer.
September 9, 2024